Food & Beverage

Tianmei Beverage Group Corporation Limited (ASX:TB8) Branded Products R&D and Promotion

🕔6/5/2017 8:23:13 AM

Tianmei Beverage Group Corporation Limited (ASX:TB8) is pleased to advise that the research and development cooperation with Guangzhou Food Industry Research Institute Co., Ltd to jointly develop technical solutions (including water composition) and production processes for Tianmei's new 'infant exclusive' bottled water, is almost complete for product launch in late 2017.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Investor Update Presentation

🕔5/31/2017 8:27:32 AM

MMJ PhytoTech Limited (ASX:MMJ) is pleased to provide the following investor update presentation, the purpose of which is to provide shareholders with an update on the Company's activities and strategic outlook following the completion of the Harvest One Transaction last month.

Read Full Article

2017 East Coles / Transplant Australia Corporate Performance Awards

🕔5/26/2017 11:35:24 AM

The 2017 East Coles / Transplant Australia Corporate Performance Awards Night will be held at the Ivy Ballroom on Thursday, 21 September.

Read Full Article

Tianmei Beverage Group Corporation Limited (ASX:TB8) Expansion of Contracted Stores and Suppliers

🕔5/18/2017 8:29:00 AM

Tianmei Beverage Group Corporation Limited (ASX:TB8) is pleased to advise that since the launch of its prospectus in late 2016, it has added another eight convenience stores and supermarkets to its network of Contracted Stores, bringing the total to 949. The new stores are located in Chenzhou City, Zhuhai City and Foshan City.

Read Full Article

2017 East Coles / Transplant Australia Corporate Performance Awards

🕔5/17/2017 2:17:14 PM

The 2017 East Coles / Transplant Australia Corporate Performance Awards will be held at the Ivy Ballroom in September.

Read Full Article

China Dairy Corp Ltd (ASX:CDC) Quarterly Trading Update Ending 31 March 2017

🕔5/17/2017 8:30:33 AM

China Dairy Corp Ltd (ASX:CDC) expects long term performance and competitiveness to be driven by herd optimisation. The Company is continuing to work on its initiatives to optimise the structure of the herd to primarily increase the proportion of milkable cows.

Read Full Article

MMJ PhytoTech Ltd (ASX:MMJ) Receives Approval to Conduct Phase 2 Clinical Trial for Treatment of Multiple Sclerosis Symptoms

🕔5/15/2017 8:27:22 AM

MMJ PhytoTech Ltd (ASX:MMJ) is pleased to advise that its wholly-owned, Israeli-based subsidiary PhytoTech Therapeutics Limited, has received Helsinki and Ministry of Health approvals for the conducting of its Phase 2 clinical study into the safety and efficacy of its PTL201 capsules in treating spasticity related symptoms of multiple sclerosis patients.

Read Full Article